Cronos vs Glass House Brands
CRON and GLAS side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRON and GLAS compare
Cronos grew revenue faster over the last twelve months (55.8% versus −9.4% for Glass House Brands).
Cronos keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with −16.3% at Glass House Brands.
Cronos scores higher on the StockData Score (15 against 5 for Glass House Brands), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRON | GLAS |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | – |
| Share price | $3.45 | $1.87 |
| Change, 1 year | 34.8% | −75.9% |
| Change, 5 years | −30.0% | −58.9% |
| Beta (5Y) | 0.85 | 0.73 |
| Employees | 610 | 472 |
| StockData Score | ||
| Total score | 15 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 3 | 3 |
| Health score | 6 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.3× | – |
| P/S | 6.2× | – |
| P/B | 1.2× | – |
| EV/EBITDA | 38.3× | – |
| P/FCF | 19.4× | – |
| FCF yield | 5.1% | – |
| Fair value | $3.66 | – |
| Margin of safety | 5.7% | – |
| Growth | ||
| Revenue growth (TTM) | 55.8% (better) | −9.4% |
| Revenue growth, 5Y average | 25.7% | 30.4% (better) |
| Net income growth (TTM) | 60.2% (better) | −5815% |
| EPS growth (TTM) | 70.0% | – |
| Profitability | ||
| Gross margin | 46.6% (better) | 42.3% |
| Operating margin | 3.4% (better) | −9.1% |
| Net margin | 28.0% (better) | −16.3% |
| FCF margin | 31.7% (better) | −8.6% |
| Return on equity | 5.4% (better) | −31.2% |
| Return on invested capital | 2.4% (better) | −9.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.93 (better) |
| Interest coverage | – | −2.3× |
| Current ratio | 12.71 (better) | 1.78 |
| Altman Z-score | 11.97 | – |
| Piotroski F-score | 7 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 3.7% | – |
| Shareholder yield | 3.7% | – |
| Ownership | ||
| Held by institutions | 12.9% | 24.9% |
| Held by insiders | 7.0% | 0.04% |
| Insider net buying, 12 months | – | −$354K |
| Short interest, % of float | 1.2% | 0.82% |
Go deeper
- CRON stock overview
- CRON income statement
- CRON valuation and score
- GLAS stock overview
- GLAS income statement
- GLAS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.